Argyriou, A.A.; Dermitzakis, E.V.; Xiromerisiou, G.; Rallis, D.; Soldatos, P.; Litsardopoulos, P.; Vikelis, M.
Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry. J. Clin. Med. 2023, 12, 3218.
https://doi.org/10.3390/jcm12093218
AMA Style
Argyriou AA, Dermitzakis EV, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P, Vikelis M.
Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry. Journal of Clinical Medicine. 2023; 12(9):3218.
https://doi.org/10.3390/jcm12093218
Chicago/Turabian Style
Argyriou, Andreas A., Emmanouil V. Dermitzakis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, and Michail Vikelis.
2023. "Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry" Journal of Clinical Medicine 12, no. 9: 3218.
https://doi.org/10.3390/jcm12093218
APA Style
Argyriou, A. A., Dermitzakis, E. V., Xiromerisiou, G., Rallis, D., Soldatos, P., Litsardopoulos, P., & Vikelis, M.
(2023). Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry. Journal of Clinical Medicine, 12(9), 3218.
https://doi.org/10.3390/jcm12093218
